Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 79 recruiting now early-phase tilt #48 of 28,707 conditions

Dementia: early-phase trial registry

79 of 202 indexed Dementia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #48 of 28,707 conditions by registered trial count.

202 US clinical trials · 79 currently recruiting · #48 of 28,707 conditions by registered trial count

Dementia: 202 US clinical trials tracked, 79 recruiting.

Dementia is the subject of 202 registered US clinical trials on ClinicalTrials.gov, 79 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most active sponsor is University of Washington, running 8 of these trials.

Enrollment posture brief

Registry condition dementia

OPEN 79 | RECR 39% | LATE 13 | EARLY 29 | RANK #48 | SPON 8

Nearest open-share peer: Advanced Non-Small-Cell Lung Cancer (39% recruiting · 23 trials)

Spinal Cord Injuries53.2%Glioblastoma39%Dementia (this)39%Atrial Fibrillation29.4%Rheumatoid Arthritis18.6%
Open-enrollment share among volume-matched conditions near Dementia

Dementia lists 79 open slots (39% of 202 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Dementia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Dementia is recruiting above its size-band peers.

    79 of 202 indexed trials (39.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Dementia trials is spread across many organizations.

    University of Washington accounts for 8 of 202 trials (4%). 110 distinct sponsors appear on at least one study for this condition label.

  3. Typical Dementia enrolment sits around 154 participants.

    Median target enrolment is 154 among the 200 trials that report a genuine target (sentinel values excluded). 80 of those (40%) plan for fewer than 100 participants.

  4. Dementia research is mostly interventional.

    157 interventional and 45 observational studies make up this index (77.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 110Phase 219Phase 310Phase 43

Open and recent trials

202 total, page 4 of 5

COMPLETED NA 154 participants

Efficacy of Early Stage Alzheimer's Support Groups

University of Washington

NCT00391794

COMPLETED Phase 2 150 participants

iCare Stress Management e-Training for Dementia Family Caregivers

Photozig

NCT01378195

COMPLETED NA 135 participants

Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention

NYU Langone Health

NCT02347202

COMPLETED Phase 3 125 participants

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Otsuka Pharmaceutical Development & Commercialization

NCT00095719

COMPLETED NA 109 participants

Anticipating Decline and Providing Therapy

Wake Forest University Health Sciences

NCT06182995

COMPLETED 108 participants

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia

National Institute of Mental Health (NIMH)

NCT00613119

COMPLETED Phase 3 107 participants

High Intensity Light Therapy in Alzheimer's Disease

National Center for Complementary and Integrative Health (NCCIH)

NCT00065689

COMPLETED Phase 1 99 participants

Encouraging Cognitive Screenings at African American Churches

University of Kansas Medical Center

NCT05037578

COMPLETED Phase 2 95 participants

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Eli Lilly and Company

NCT04640077

COMPLETED NA 88 participants

Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI

University of Alabama at Birmingham

NCT03734289

COMPLETED Phase 2 88 participants

Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia

VA Office of Research and Development

NCT02350127

COMPLETED NA 86 participants

Community-based Brain Health Program to Address Dementia Risk

Posit Science Corporation

NCT05529706

COMPLETED NA 80 participants

Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers

Elizabeth K Rhodus

NCT05202223

COMPLETED NA 75 participants

Caregiver Study Dr. Phillips

AdventHealth

NCT03653871

COMPLETED Phase 2 64 participants

A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

CuraSen Therapeutics

NCT05104463

COMPLETED NA 61 participants

Effect of Treating Sleep Apnea on Cognition in Patients With Dementia

University of California, San Diego

NCT00477828

COMPLETED 60 participants

Families Affected by Dementia: A Survey of Caregivers

University of Miami

NCT02095327

COMPLETED NA 60 participants

Powerful Tools for Caregivers of Dementia Patients

Florida State University

NCT02697721

COMPLETED NA 50 participants

Effects on Dementia Caregivers

University of Central Florida

NCT06473571

COMPLETED NA 45 participants

Training and Coaching to Promote High Performance in Veteran Affairs (VA) Nursing Home Care

US Department of Veterans Affairs

NCT00875706

COMPLETED NA 42 participants

Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program

Emory University

NCT02300584

COMPLETED NA 42 participants

Providing Evidence-Based Approaches for Caregiver Stress Study

Johns Hopkins Bloomberg School of Public Health

NCT06451250

COMPLETED NA 38 participants

Assessing a Novel Virtual Environment That Assists With Activities of Daily Living

mandy

NCT05418296

COMPLETED 37 participants

Daily Study of Caregiving Relationships and Health

The University of Texas Health Science Center at San Antonio

NCT04682535

COMPLETED 32 participants

Family Involvement Hospital Ethnography

Duke University

NCT06374992

COMPLETED NA 31 participants

CAPABLE Transitions: A Home Health-Based Intervention for the Hospital or Post-Acute Care Facility-to-Home Transition

University of Rochester

NCT04460742

COMPLETED NA 30 participants

Socially Isolated Older Adults Living With Dementia

University of Washington

NCT03666624

COMPLETED 30 participants

Connectomics in Psychiatric Classification

Washington University School of Medicine

NCT03967535

COMPLETED NA 27 participants

Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment

University of Texas Southwestern Medical Center

NCT05564715

COMPLETED NA 26 participants

SimpleC Wellness Platform With Social Robot Interaction

SimpleC

NCT05296239

COMPLETED NA 25 participants

Movement Intervention for Memory Enhancement

Albert Einstein College of Medicine

NCT03475316

COMPLETED NA 21 participants

Patient Priorities Care for Hispanics With Dementia

The University of Texas Medical Branch, Galveston

NCT05303194

COMPLETED Phase 2 20 participants

Double Blind Trial of DC Polarization in FTD

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00117858

COMPLETED NA 20 participants

Brain Changes With Game Training in Aging

University of Wisconsin, Madison

NCT02490137

COMPLETED Phase 2 20 participants

Effect of Insulin Sensitizer Metformin on AD Biomarkers

University of Pennsylvania

NCT01965756

COMPLETED NA 20 participants

Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia

Johns Hopkins University

NCT00294554

COMPLETED NA 20 participants

Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)

University of California, San Francisco

NCT02403752

COMPLETED NA 20 participants

Zolpidem CR and Hospitalized Patients With Dementia

Massachusetts General Hospital

NCT00814502

COMPLETED NA 20 participants

"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"

Alzheimer's Disease Cooperative Study (ADCS)

NCT05350410

COMPLETED NA 19 participants

Pilot Mobile for Dementia and Frailty

University of Washington

NCT05827094

COMPLETED NA 18 participants

Rhythmically Entrained Exercise in Community-Dwelling Older Adults

University of North Carolina, Greensboro

NCT05462977

COMPLETED NA 18 participants

Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living

Vanderbilt University

NCT05956665

COMPLETED NA 15 participants

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes

University of California, Berkeley

NCT05159583

COMPLETED NA 14 participants

Our Care Wishes - Dementia

University of Pennsylvania

NCT05033262

COMPLETED Phase 4 12 participants

Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

Baylor Research Institute

NCT03817931

COMPLETED Phase 4 11 participants

Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)

VA Office of Research and Development

NCT00385684

COMPLETED NA 10 participants

Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks

University of Oregon

NCT05007730

COMPLETED Phase 1 10 participants

Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine

Mayo Clinic

NCT02131545

COMPLETED NA 6 participants

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

University of California, Berkeley

NCT05159596

COMPLETED NA 4 participants

Yoga for Caregivers and Persons With Dementia

Wake Forest University Health Sciences

NCT05103839

← Previous Page 4 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 10
Phase 2 19
Phase 3 10
Phase 4 3

Named interventions

Most-linked intervention names on Dementia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
11 trials
Usual Care Other
3 trials
Limited In-Home Technology Device
2 trials
In-Home Technology System Device
2 trials
Matching Placebo (Remternetug) Drug
2 trials
No interventions Other
2 trials
NeuroElectric StarStim Device
1 trials
Performing Arts Instruction Behavioral
1 trials

US sites by state

Facility locations filed on Dementia trials. A trial with sites in several states counts in each.

California 46 trials
Florida 26 trials
Texas 23 trials
New York 23 trials
North Carolina 19 trials
Maryland 18 trials
Massachusetts 18 trials
Georgia 18 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Dementia page

202 registered trials, 79 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia condition card totals 202 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.